Rna Targeting in Alpha-synucleinopathies
Therapies and assays to screen for small molecules that can have therapeutic use in the control of neurodegenerative diseases such as Parkinson's and other alpha-synucleinopathies.
Attached files:Patents:WO 2,010,129,791
Inventor(s):
MOURADIAN MARY MARAL [US]; JUNN EUNSUNG [US]
Type of Offer:
Licensing
« More Medical Patents